Safety and efficacy of irinotecan plus high-dose leucovorin and intravenous bolus 5-fluorouracil for metastatic colorectal cancer: pooled analysis of two consecutive southern Italy cooperative oncology group trials.

Clinical colorectal cancer

Volumn 5, Issue 3, 2005, Pages 203-210

  Comella, Pasquale ^a   Massidda, Bruno ^a   Filippelli, Gianfranco ^a   Natale, Donato ^a   Farris, Antonio ^a   Buzzi, Franco ^a   Tafuto, Salvatore ^a   Maiorino, Luigi ^a   Palmeri, Sergio ^a   De Lucia, Luigi ^a   Mancarella, Sergio ^a   Leo, Silvana ^a   Roselli, Mario ^a   Lorusso, Vito ^a   De Cataldis, Giuseppe ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INJECTIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 32944478828     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2005.n.032     Document Type: Article

References (0)